Terug
44
Dagbereik
€ 80,54
€ 82,46
52-Weeksbereik
€ 72,76
€ 116,65
Volume
748.070
50D / 200D Gem.
€ 80,99
/
€ 92,37
Vorige Slotkoers
€ 81,02
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 32,4 | 0,4 |
| P/B | 3,3 | 2,9 |
| ROE % | 10,2 | 3,7 |
| Net Margin % | 16,4 | 3,8 |
| Rev Growth 5Y % | 14,8 | 10,0 |
| D/E | 0,5 | 0,2 |
Belangrijkste Punten
Revenue grew 14,79% annually over 5 years — strong growth
Earnings grew 122,54% over the past year
ROE of 10,19% — decent returns on equity
Net margin of 16,38% shows strong profitability
Debt/Equity of 0,48 — conservative balance sheet
Generating 455,13M in free cash flow
Groei
Revenue Growth (5Y)
14,79%
Revenue (1Y)9,47%
Earnings (1Y)122,54%
FCF Growth (3Y)52,09%
Kwaliteit
Return on Equity
10,19%
ROIC7,78%
Net Margin16,38%
Op. Margin24,55%
Veiligheid
Debt / Equity
0,48
Current Ratio3,27
Interest Coverage5,64
Waardering
P/E Ratio
32,41
P/B Ratio3,31
EV/EBITDA23,75
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 9,47% | Revenue Growth (3Y) | 14,63% |
| Earnings Growth (1Y) | 122,54% | Earnings Growth (3Y) | 96,54% |
| Revenue Growth (5Y) | 14,79% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1,31B | Net Income (TTM) | 215,20M |
| ROE | 10,19% | ROA | 6,27% |
| Gross Margin | 69,52% | Operating Margin | 24,55% |
| Net Margin | 16,38% | Free Cash Flow (TTM) | 455,13M |
| ROIC | 7,78% | FCF Growth (3Y) | 52,09% |
| Safety | |||
| Debt / Equity | 0,48 | Current Ratio | 3,27 |
| Interest Coverage | 5,64 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 32,41 | P/B Ratio | 3,31 |
| P/S Ratio | 5,31 | PEG Ratio | 0,27 |
| EV/EBITDA | 23,75 | Dividend Yield | 0,00% |
| Market Cap | 6,98B | Enterprise Value | 7,66B |
Income Statement
Annual, most recent first
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 1,31B | 1,20B | 999,59M | 861,75M | 756,56M |
| Net Income | 215,20M | 96,70M | 55,71M | -26,14M | -44,29M |
| EPS (Diluted) | 2,46 | 1,09 | 0,64 | -0,31 | -0,53 |
| Gross Profit | 913,12M | 692,58M | 529,87M | 395,51M | 340,92M |
| Operating Income | 322,46M | 230,07M | 128,13M | 37,65M | 40,57M |
Balance Sheet
Annual, most recent first
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Total Assets | 3,43B | 3,45B | 3,16B | 3,09B | 3,11B |
| Total Liabilities | 1,32B | 1,33B | 1,13B | 1,19B | 1,25B |
| Shareholders' Equity | 2,11B | 2,11B | 2,04B | 1,90B | 1,85B |
| Total Debt | 1,00B | 1,11B | 933,14M | 994,49M | 1,01B |
| Cash & Equivalents | 318,93M | 295,95M | 403,98M | 254,27M | 225,41M |
| Current Assets | 512,28M | 477,75M | 557,44M | 382,89M | 351,34M |
| Current Liabilities | 156,85M | 156,32M | 117,09M | 131,06M | 153,19M |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#546 of 1024
Recente Activiteit
Ingestapt
Cash Flow Compounder
Mar 24, 2026